Syndromic Testing · Oct 2026 · 5 min read · By Laboratory House
Syndromic PCR tests one sample against many likely pathogens at once, chosen by the patient’s symptoms rather than one suspected organism. It is increasingly used for respiratory, gastrointestinal, bloodstream and central nervous system infections.
The problem it solves
Fever, cough, diarrhoea and headache are produced by dozens of organisms. In the traditional approach a clinician guesses the most likely cause, orders one test, waits, and orders another if it is negative. Each step adds hours, and treatment is often started empirically in the meantime.
How it works
The clinician selects a panel, such as upper respiratory, gastrointestinal, meningitis or blood culture. A cartridge-based system extracts nucleic acid and amplifies all targets in a single automated run. On the Ultra Multiplex Syndromic PCR that takes 60–70 minutes, with about a minute of hands-on time.
Why hospitals adopt it
- Fewer repeat tests because one run covers many possibilities.
- Faster treatment decisions when the organism is known sooner.
- Better use of isolation beds because infectious and non-infectious causes can be separated quickly.
- Lower hands-on time, which suits laboratories with limited molecular staff.
Limits to keep in mind
A positive result shows that nucleic acid was detected, not always that the organism caused the illness. Panels do not cover every pathogen, and some targets may be research use only. Results should always be interpreted together with clinical findings, and routine culture and susceptibility testing still have a role.
Is it right for you?
Syndromic PCR works best where overlapping symptoms are common and a quick answer changes management. If most of your work is confirming one known pathogen at volume, read our comparison of multiplex PCR versus single-target RT-PCR. For the full list of panels, see Molecular & Syndromic TestingUltra Multiplex Syndromic PCR.
For healthcare professionals. Educational content only; not a substitute for clinical judgement. Product regulatory status is as per the principal’s approvals.
